8 More Big Pharma Events in 2019 You Don't Want to Miss

It's going to be an action-packed second half for a handful of big pharmaceutical companies, and perhaps the most interesting six-month stretch in Novartis' (NYSE: NVS) history. Recently launched therapies from the Swiss pharma giant and Pfizer (NYSE: PFE) will be closely watched for different reasons.